These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 30677218)

  • 1. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
    Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
    J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of OGT by Caveolin-1 promotes hepatocellular carcinoma cell migration and invasion.
    Wang L; Feng Y; Zhang C; Chen X; Huang H; Li W; Zhang J; Liu Y
    Cell Biol Int; 2021 Nov; 45(11):2251-2263. PubMed ID: 34288245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
    Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
    Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.
    Huang H; Wu Q; Guo X; Huang T; Xie X; Wang L; Liu Y; Shi L; Li W; Zhang J; Liu Y
    J Cell Physiol; 2021 Nov; 236(11):7491-7503. PubMed ID: 33843053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
    Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
    Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
    Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression.
    Lv Z; Ma G; Zhong Z; Xie X; Li B; Long D
    Carcinogenesis; 2023 Dec; 44(10-11):785-794. PubMed ID: 37218374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma.
    Wang J; Wang Z; Yuan J; Wang J; Shen X
    Aging (Albany NY); 2020 May; 12(9):7786-7800. PubMed ID: 32357142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromatin-associated OGT promotes the malignant progression of hepatocellular carcinoma by activating ZNF263.
    Wang L; Li G; Zhou Z; Ge C; Chen Q; Liu Y; Zhang N; Zhang K; Niu M; Li W; Zhong X; Wu S; Zhang J; Liu Y
    Oncogene; 2023 Jul; 42(30):2329-2346. PubMed ID: 37353617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
    Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
    Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
    Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
    Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
    Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
    BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-24-1 suppresses mouse hepatoma cell invasion and metastasis via directly targeting O-GlcNAc transferase.
    Liu Y; Huang H; Liu M; Wu Q; Li W; Zhang J
    Biomed Pharmacother; 2017 Jul; 91():731-738. PubMed ID: 28499244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation.
    Chu Y; Jiang M; Wu N; Xu B; Li W; Liu H; Su S; Shi Y; Liu H; Gao X; Fu X; Chen D; Li X; Wang W; Liang J; Nie Y; Fan D
    Theranostics; 2020; 10(21):9830-9842. PubMed ID: 32863962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
    Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
    J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.
    Shan X; Jiang R; Gou D; Xiang J; Zhou P; Xia J; Wang K; Huang A; Tang N; Huang L
    FEBS J; 2023 Sep; 290(18):4543-4561. PubMed ID: 37247228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.